Serum α1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients

Renal Failure

Volumn 25, Issue 4, 2003, Pages 589-593

  Borawski, Jacek ^a   Naumnik, Beata ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

1 Antitrypsin; C3 and C4 of complement; Hemodialysis; Inflammation

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; LIPOPROTEIN; OROSOMUCOID; VON WILLEBRAND FACTOR; LIPOPROTEIN A; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOALBUMINEMIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; INFLAMMATION; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; RENAL REPLACEMENT THERAPY; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; COMPLEMENT C3; COMPLEMENT C4; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; LIPOPROTEIN(A); MALE; MIDDLE AGED; OROSOMUCOID; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; SERUM ALBUMIN; STATISTICS; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 0042623771     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120022550     Document Type: Article

References (13)

1. Locatelli, F.; Bommer, J.; London, G.M.; Martin-Malo, A.; Wanner, C.; Yaqoob. M.; Zoccali, C. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol. Dial. Transplant. 2001, 16, 459-468.
2. Stenvinkel, P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001, 19, 53-61.
3. Zimmermann, J.; Herrlinger, S.; Pruy, A.; Metzger, T.; Wanner, C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999, 55, 648-658.
4. Yeun, J.Y.; Levine, R.A.; Mantadilok, V.; Kaysen, G.A. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis. 2000, 35, 469-476.
5. Kaysen, G.A.; Dubin, J.A.; Muller, H.G.; Mitch, W.E.; Levin, N.W. The HEMO Group. Levels of alphal acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int. 2001, 60, 2360-2366.
6. Irish, A. Cardiovascular disease, fibrinogen and the acute phase response associations with lipids and blood pressure in patients with chronic renal failure. Atherosclerosis 1998, 137, 133-139.
7. Borawski, J.; Naumnik, B.; Pawlak, K.; Mysliwiec, M. Endothelial dysfunction marker von Willebrand factor antigen in hemodialysis patients: associations with predialysis blood pressure and the acute phase response. Nephrol. Dial. Transplant. 2001, 16, 1442-1447.
8. Zoccali, C.; Bode-Boger, S.; Mallamaci, F.; Benedetto, F.; Tripepi, G.; Malatino, L.; Cataliotti, A.; Bellanuova, I.; Fermo, I.; Frolich, J. Plasma concentration of asymmetrical dimetyloarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001, 358, 213-217.
9. Kario, K.; Matsuo, T.; Kobayashi, H.; Matsuo, M.; Asada, R.; Koide, M. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb. Hemost. 1995, 74, 1020-1024.
10. Borawski, J.; Mysliwiec, M. The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients. Nephron 2001, 89, 281-383.
11. Zoccali, C.; Mallamaci, F.; Tripepi, G.; Benedetto, F.A.; Cutrupi, S.; Parlongo. S.; Malatino, L.S.; Bonanno, G.; Seminara, G.; Rapisarda, F.; Fatuzzo, P.; Buemi, M.; Nicocia, G.; Tanaka, S.; Ouchi, N.; Kihara, S.; Funahashi, T.; Matsuzawa, Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2002, 13, 134-141.
12. Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340, 448-454.
13. Koj, A. The Acute-Phase Response to Injury and Infection. Definition and classification of acute-phase proteins. Gordon, A.H., Koj. A., Eds.; Elsevier Science Publishers: Amsterdam, 1985; pp. 139-144.